News
Global Generic Injectables Market. Dublin, April 27, 2022 (GLOBE NEWSWIRE) -- The "Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Container Type ...
Low Investment Costs to Heighten Generic Injectables Market Growth ProspectsGlobal generic injectables market is forecast to expand impressively at a CAGR of 13.3% during the forecast period ...
Global generic injectables market is forecast to expand impressively at a CAGR of 13.3% during the forecast period (2020-2025). Governments worldwide are encouraging distribution and development of ...
The global generic injectables market is projected to grow from $106.1 billion in 2024 to $206.8 billion by 2030, at an 11.8% CAGR. Key growth drivers include patent expirations, increasing demand for ...
The generic sterile injectables market accounted for $ 68.7 billion in 2019 and is estimated to be $196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%, per a report from Prophecy ...
Biologics, generics and contract services will drive 10% annual growth, according to CPhI’s annual industry report At the CPhI conference in Madrid this week, Vivek Sharma, CEO of Pharma Solutions, ...
The companies announced an agreement where Dorizoe will work with Baxter to develop more than 20 generic injectable products. On June 14, 2017, Baxter International announced that it has entered into ...
CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated generic injectables company based in Chicago, today announced it has expanded its portfolio of generic ...
Global Generic Injectables Market Global Generic Injectables Market Dublin, April 27, 2022 (GLOBE NEWSWIRE) -- The "Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Global Analysis By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results